Royal Fund Management, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Royal Fund Management, LLC

  • $1.04 Billion
  • Q4 2024

A detailed history of Royal Fund Management, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Royal Fund Management, LLC holds 62,600 shares of XBI stock, worth $5.5 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
62,600
Previous 296,486 78.89%
Holding current value
$5.5 Million
Previous $29.3 Million 80.76%
% of portfolio
0.54%
Previous 1.77%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
SELL
$89.81 - $104.0 $21 Million - $24.3 Million
-233,886 Reduced 78.89%
62,600 $5.64 Million
Q3 2024

Oct 08, 2024
BUY
$90.87 - $102.43 $21.4 Million - $24.2 Million
235,835 Added 388.84%
296,486 $29.3 Million
Q2 2024

Jul 18, 2024
BUY
$82.22 - $94.12 $4.99 Million - $5.71 Million
60,651 New
60,651 $5.62 Million
Q1 2018

May 07, 2020
SELL
N/A
-102 Closed
0 $0
Q4 2017

May 07, 2020
BUY
N/A
102
102 $8,000

Others Institutions Holding XBI

# of Institutions
916
Shares Held
102M
Call Options Held
27.4M
Put Options Held
38.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Royal Fund Management, LLC Portfolio

Follow Royal Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email